Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Pfizer